Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Explanation for the 336 re-ex denial is available

Explanation for the 336 re-ex denial is available

posted on Aug 04, 2009 07:27AM

17 pages why Uhlendorf and Ledzius don't justify another re-exam for the '336.

What I didn't know (and how I understand it): the request was made by HTC, Acer, Barco and Sirius, which are all represented by White & Case in Palo Alto.

Besides it says "a ruling on the response is pending before USPTO". The response was written by us on May, 12...so let's hope the USPTO is seeking to terminate this whole process as soon as possible.

GLTA

Share
New Message
Please login to post a reply